During the past decade, Pharma Research International Inc conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 5 clinical trials were completed, i.e. on average, 62.5% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 5 clinical trials were completed. i.e. 250% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Pharma Research International Inc" #1 sponsor was "Shire" with 5 trials, followed by "Arbor Pharmaceuticals, Inc." with 2 trials sponsored, "Dr. Reddy's Laboratories Limited" with 1 trials sponsored, "Eli Lilly and Company" with 1 trials sponsored and "Frontier Biotechnologies Inc." with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Pharma Research International Inc" #1 collaborator was "Arena is a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator and "Parexel" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Pharma Research International Inc" are "Crohn's Disease" (4 trials), "Ulcerative Colitis" (4 trials), "Acute Otitis Media" (2 trials), "Chronic Idiopathic Constipation" (1 trials) and "Chronic Low Back Pain" (1 trials). Many other conditions were trialed in "Pharma Research International Inc" in a lesser frequency.

Most popular intervention types in "Pharma Research International Inc" are "Drug" (10 trials), "Other" (4 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Ontamalimab" (4 trials), "AR01" (2 trials), "25 mg Ontamalimab" (1 trials) and "75 mg Ontamalimab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Pharma Research International Inc" are 11 trials for "All" genders.

Currently, there are NaN active trials in "Pharma Research International Inc". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Pharma Research International Inc, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Pharma Research International Inc, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".